LeonaBio (LONA) Current Assets (2019 - 2026)
LeonaBio (LONA) posted quarterly Current Assets of $69.2 million for Q1 2026, up 73.64% year-over-year from $39.9 million in Q1 2025, and down 22.64% quarter-over-quarter from $89.5 million in Q4 2025.
LeonaBio (LONA) Current Assets (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Current Assets for 8 consecutive years, with $69.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 73.64% year-over-year to $69.2 million; the TTM figure through Mar 2026 stood at $69.2 million (up 73.64% YoY), while the FY2025 annual figure was $89.5 million, up 63.12% from the prior year.
- Current Assets eased to $69.2 million in Q1 2026 per LONA's latest filing, from $89.5 million in the prior quarter.
- Across five years, Current Assets topped out at $269.2 million in Q1 2022 and bottomed at $27.0 million in Q3 2025.
- Historically, Current Assets has averaged $135.9 million across 5 years, with a median of $128.6 million in 2024.
- Annual changes were most pronounced in 2025 — Current Assets slumped 69.81% — and 2026, when it jumped 73.64%.
- LeonaBio's Current Assets stood at $207.5 million in 2022, then declined by 25.44% to $154.7 million in 2023, then slumped by 64.56% to $54.8 million in 2024, then soared by 63.12% to $89.5 million in 2025, then fell by 22.64% to $69.2 million in 2026.
- Business Quant data shows LONA's Current Assets at $69.2 million in Q1 2026, $89.5 million in Q4 2025, and $27.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | 54.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.20 Mn |
| Dec 31, 2025 | 89.46 Mn |
| Sep 30, 2025 | 27.03 Mn |
| Jun 30, 2025 | 32.22 Mn |
| Mar 31, 2025 | 39.85 Mn |
| Dec 31, 2024 | 54.84 Mn |
| Sep 30, 2024 | 82.00 Mn |
| Jun 30, 2024 | 106.70 Mn |
| Mar 31, 2024 | 128.64 Mn |
| Dec 31, 2023 | 154.73 Mn |
| Sep 30, 2023 | 178.50 Mn |
| Jun 30, 2023 | 192.13 Mn |
| Mar 31, 2023 | 192.90 Mn |
| Dec 31, 2022 | 207.53 Mn |
| Sep 30, 2022 | 228.97 Mn |
| Jun 30, 2022 | 255.86 Mn |
| Mar 31, 2022 | 269.15 Mn |
| Dec 31, 2021 | 260.80 Mn |
| Sep 30, 2021 | 238.99 Mn |
| Jun 30, 2021 | 290.50 Mn |